Possible paracrine mechanism of insulin-like growth factor-2 in the development of liver metastases from colorectal carcinoma
Authors:
Open Access
Abstract
BACKGROUND Insulin‐like growth factor‐2 (IGF‐2) is considered one of the autocrine growth factors in colorectal carcinoma. In addition, it is well known that IGF‐2 is produced in the liver. However, the role of IGF‐2 in liver metastasis is not yet understood clearly. METHODS Immunohistochemical staining of IGF‐2 and IGF‐1 receptor (IGF‐1R) was performed on tissue samples of liver metastases from 30 colorectal carcinoma patients. In situ hybridization of IGF‐2 also was conducted on the same tissue samples. Furthermore, proliferating cell nuclear antigen (PCNA) was immunohistochemically stained for use as an indicator of the proliferative activity of cancer cells. RESULTS Invasive margins of liver metastases were stained highly by both IGF‐2 (70%) and IGF‐1R (83%). Overexpression of IGF‐2 protein and mRNA was observed in the normal liver adjacent to the tumor. The PCNA labeling indices (LIs) of the IGF‐2 positive groups were significantly higher than those of the IGF‐2 negative group (P < 0.0001). In addition, the PCNA LIs for the IGF‐1R positive groups also were significantly higher than those for the IGF‐1R negative group (P = 0.0002). CONCLUSIONS These findings suggest that hepatocyte‐derived IGF‐2 stimulates tumor cell proliferation by a paracrine mechanism and plays an important role in tumor progression in colorectal carcinoma patients with liver metastases. Cancer 1999;85:18–25. © 1999 American Cancer Society.Keywords
This publication has 17 references indexed in Scilit:
- Expression of Insulin-Like Growth Factor-2 Can Predict the Prognosis of Human Colorectal Cancer Patients: Correlation with Tumor Progression, Proliferative Activity and SurvivalOncology, 1998
- Molecular mechanisms for organ-specific colon carcinoma metastasisEuropean Journal of Cancer, 1995
- Blockade of the insulin‐like growth‐factor‐I receptor inhibits growth of human colorectal cancer cells: Evidence of a functional IGF‐II‐mediated autocrine loopInternational Journal of Cancer, 1994
- Processing of insulin-like growth factor-II (IGF-II) by human breast cancer cellsMolecular and Cellular Endocrinology, 1994
- Insulin-like growth factor II in two human colon-carcinoma cell lines: Gene structure and expression, and protein secretionInternational Journal of Cancer, 1992
- Abnormal expression and structural modification of the insulin‐like growth‐factor‐ii gene in human colorectal tumorsInternational Journal of Cancer, 1990
- Primary structure of human skeletal growth factor: homology with human insulin-like growth factor-IIBiochimica et Biophysica Acta (BBA) - General Subjects, 1988
- Expression of Somatomedin/Insulin-Like Growth Factor Messenger Ribonucleic Acids in the Human Fetus: Identification, Characterization, and Tissue Distribution*The Journal of Clinical Endocrinology & Metabolism, 1988
- Elevated concentration of IGF II in brain tissue from an infant with macrencephalyThe Journal of Pediatrics, 1986
- THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST.The Lancet, 1889